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Summary
Elimination of potentially self-reactive T lymphocytes during their maturation in the thymus
has been shown to be a major mechanism in accomplishing self-tolerance. Previous reports
demonstrated that clonal deletion of self-Mls-la-specific V,36+ T lymphocytes is controlled by
a radiosensitive I-E+ thymic component. Irradiation chimeras reconstituted with I-E - bone
marrow showed substantial numbers of mature V06+ T cells despite host MIS-1a expression.
Analysis of the functional properties of such chimeric T cells revealed a surprising variability
in their in vitro reactivity to host Mls-1a, depending on the H-2 haplotype ofstem cells used
for reconstitution. In chimeras reconstituted with B10.S (H-2') stem cells, mature Va6+ lym-
phocytes were present but functionally anergic to host-type Mls-1a in vitro. In contrast, in
chimeras reconstituted with B10.G (H-29) bone marrow, nondeleted V)36+ cells were highly
responsive to MIS-1a in vitro. These findings suggest that clonal anergy of V$6+ cells to self-
Mls-1a may be controlled by the affinity/avidity of T cell receptor interactions with bone
marrow-derived cells in the thymus depending on the major histocompatibility complex class
II molecules involved. Furthermore, chimeras bearing host (Mls-la)-reactive V06+ cells did not
differ clinically from those with anergic or deleted V06+ cells and survived more than one year
without signs of autoimmune disease. Interestingly, their spleen cells had no Mls-1a stimulatory
capacity in vitro. Therefore, regulation at the level of antigen presentation may be an alternative
mechanism for maintenance of tolerance to certain self-antigens such as Mls-la.
mmunological tolerance to self determinants is thought
to be accomplished by several distinct mechanisms. Re-
cently, it has been shown that clonal deletion of self-specific
T cells in the thymus is a major factor controlling autoreac-
tivity of the immune system (1-11). For example, mice of
Mls-1a genotype have been found to clonally delete mature
T cells expressing TCR V06, V08.1, V09, and V07, all four
of which confer specificity to Mls-1a (2, 3, 11, 12). The cel-
lular basis of clonal deletion was further studied in irradia-
tion bone marrow chimeras. V06+ T cells have been shown
to be deleted independent of MIS-1a being expressed by
donor or host tissue (6, 13). This indicates that irradiated
recipient mice express sufficient Mls-1a to tolerize immature
lymphocytes. However, we (14, 15) and others (16-18) have
demonstrated that deletion of V)36+ T cells in chimeras re-
quired MHC class II (I-E) expression on donor bone marrow-
derived cells, thus suggestingan important role for presenta-
tion of self-Mls-1a by hemopoietic cells in the thymus.
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Besides clonal deletion, other mechanisms have been im-
plicated in the maintenance of self-tolerance. Recently, T cells
specific for (but not reactive to) self-antigens have been
identifiedin immunized (19), chimeric(16, 17, 20), and trans-
genic (21-25) mice. This unresponsiveness (frequently referred
to as anergy) was found among thymic and/or peripheral T
lymphocytes; however, the molecular basisof anergy remains
obscure.
To investigate the mechanism(s) ofunresponsiveness in more
detail, we took advantage of the fact that effective deletion
of V06+ (Mls-la-specific) T cells in irradiation bone marrow
chimeras depends upon the H-2 haplotype ofdonor stem tells
used for reconstitution (14-18). In particular, the functional
properties of V06+ T cells that escaped clonal deletion were
investigated and compared with T cells from chimeras where
clonal deletion was effective. Lymphocytes from chimeras
reconstituted with B10.S (I-E - ) bone marrow cells re-
sponded very weakly to host-type Mls-1' stimulator cells,
J. Exp. Med. ® The Rockefeller University Press - 0022-1007/90/11/1305/10 $2.00
Volume 172 November 1990 1305-1314confirming other recent examples of clonal anergy (16, 17,
19, 20, 25). In contrast, T cellsfrom similarrecipients recon-
stituted with B10.G (I-E') bone marrow reactedvigorously
to host-type Mls-1' stimulator cells in vitro. These data in-
dicate first that clonal anergy (at least in the Mls-1' system)
is controlled by hemopoietic cells, and second, that T cell
unresponsiveness in vivo mayin some cases depend on mech-
anisms otherthan clonal anergy, e.g., absence ofappropriate
antigen presentation in vivo.
Materials and Methods
Animals.
￿
Inbred DBA/2 (H-2d), BALB/c (H-2d), B10.D2 (H-
2d), B10.BR (H-2t .), and C57BL/6 (H-26) mice were purchased
from theInstitutefiir Zuchthygiene, Tierspital, University ofZurich,
Switzerland. B10.G (H-29) and B10.S (H-2') mice were obtained
from Olac, Bicester, Oxon, UK. BALRD2-Mls' (26) breeders
were kindly provided by Dr.Hilliard Festenstein, London Hospital
Medical College, UK. BALB.D2-Mls' (also referred to as
BALRD2) and hybrid F, mice were bred locally. Characteristics
of these strains relevant to the present study are summarized in
Table 1.
Chimeras.
￿
Bone marrow recipients were lethally radiated (950
rad, 117 rad/min, ,31Cs source) and reconstituted 1 d later with
2 x 10'T cell-depleted bone marrow cells (27). For the following
8wk, chloramphenicol (0.4 g/liter) wasaddedto thedrinkingwater.
The transplanted mice had a survival rate of 85-100%. Analysis
was performedbetween7and 16 wk afterreconstitution. Chimerism
wasmonitoredby FACS analysis oflymphnode or spleen cellswith
H-2 haplotype-specific mAbs.
Cytofluorographic Analysis.
￿
Aliquots of thymocytes or lymph
node cells were stainedat 4°C with ratmAbs 44-22-1 (V#6 specific)
or KJ16-133 (VO&1/VS8.2 specific)followed by FITC-conjugated
goat anti-rat IgG (Tago Inc., Burlingame, CA). PE-conjugated
CD4-specific mAb GK 1.5 (Becton Dickinson & Co., Mountain
Table 1.
￿
Characteristics ofMouse Strains Used in this Study
Percentages of V06+/CD4+ lymph node cells (means of three individual mice) were determined by two-color immunofluorescence andare normal-
ized to the total CD4+ populations .
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￿
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View, CA) was used for double staining. To assess the chimerism
of transplanted mice, haplotype-specific mouse IgG2a mAbs 100-
5.28 (KkDk specific, crossreactive with H-29), 342-12 (Dd specific),
or 14
\
-
`
4
'
-4 (I-Ed,k specific), respectively, were used followed by a
fluorescent goat anti-mouse IgG2areagent (SouthernBiotechnology
Associates, Inc., Birmingham, AL). Viable cells (20,000/sample)
were analyzed by flow cytometry on a Epics Profile Analyzer
(Coulter Electronics, Inc., Hialeah, FL) with logarithmic scales.
Percentages after subtraction with the fluorescein conjugate alone
are indicated.
Mixed Lymphocyte Cultures.
￿
Responder lymphocytes (1.5 x
106) were incubated with irradiated (1,000 rad) antiThy-1.2 (mAb
AT83) plus rabbit complement-depleted splenic stimulator cells
(4.5 x 106) in 2 ml IMDM supplemented with 19 MM L-glu-
tamine, 105 U/liter penicillin-streptomycin solution, 5 x 10-s M
2-ME, and 10% heat-inactivated FCS in 24-well plates at 37°C
in 5% COZplus air. Cultures used for the assessment of ['Hlthy-
midine uptake and IL2 secretion contained 5 x 105 responder cells
and 1-10 x 105 stimulator cells in 96-well flat-bottomed plates.
In some experiments, responder populations were depleted of
CD8+ cells by treatment with rat IgM mAb 3.168.1 (CD8 speci-
fic) plus rabbit complement before culture.
IL2 Measurement .
￿
IL2contents of48-h MLC supernatants were
assayed on CTLL2 cells as described (28). IL2 values were calcu-
latedusing OD 405-nm measurements afterbackground subtrac-
tion. rIIL2 was used to calibrate a standard curve where 50% of
the maximal OD 405-nm value was arbitrarily defined as 100 U
of 11,2/ml. Consequently, 11,2 values were calculated as follows:
100 U/ml (dilution factor of sample supernatant at 50% max.
OD)/(dilutionfactor at 50% max. OD ofrIL2 standard). Growth
of CTLL2 cells o£ MLC supernatants was completely blocked by
theIL2-specific mAb S4B6, provingthat the only factor measured
wasIL2(some CTLL2cells also show aminorsensitivity to IL4).
Blast Purification.
￿
3-d MLC-responding T cell blasts were iso-
lated on a Percoll density gradient and resuspended (2 x 105 viable
cells/ml) in fresh medium supplemented with human rIL2 (200
Mouse strain Mls-1
MHC
I-A
class II
I-E Percent V/36+/CD4+ cells
DBA/2 a d d 0.4
BALB.D2-Mls' (BALB.D2) a d d 0.4
BALB/c b d d 12.4
B10.D2 b d d 9.3
B10.G b q - 3.8
B10.S b s - 8.2
B10.BR b k k 8.8
C57BL/6 b b - 7.4
(DBA/2 x B10.G)F, a/b d/q d/- 0.8
(BALB.D2-Mls' x B10.G)F, a/b d/q d/- 0.6
(BALB.D2-Mls' x B10.S)F, a/b d/s d/- 1.1ng/ml). After 2 d, cells were recovered, counted, and analyzed for
V/3 expression.
Assessment ofMls-1' Stimulatory Capacity.
￿
Spleen cells (1-10 x
105) from chimeras and control mice were cocultured with the
Mls-1'-specific T cell hybrid RG17.16 (2 x 104 cells) in 96-well
flat-bottomed plates (29). In some experiments, the stimulating
spleen cells were irradiatedwith 1,000 rad and/or T cell depleted.
No significant difference instimulatory capacity was seen between
these treatment protocols. 11,2 contents of supernatants were de-
termined as described above.
Results
Chimeras Reconstituted with I-E - Bone Marrow Show Im-
paired Clonal Deletion of V(36+ T Cells. We constructed
semiallogeneic parent - Ft chimeras using either B10.D2
(H-2d), B10.S (H-2S), or B10.G (H-2q) mice as donors of T
cell-depleted bone marrow. Recipients were either (BALB.D2-
Mls' x B10.S)Ft or (BALRD2-Mls' x B10.G)Ft mice. As
shown in Table 2, both types of transplanted animals that
received I-E - stem cells from B10.S or B10.G mice, respec-
tively, revealed impaired clonal deletion of V/36+ (Mls-1'-
specific) cells. In contrast, chimeras transplanted with B10.D2
(I-E+) bone marrow showed low levels of V#6+ cells. Com-
parable results have been obtained in irradiated (DBA/2 x
B10.G)Ft mice reconstituted with either B10.G or B10.D2
bone marrow cells; recipientsreconstituted with DBA/2 stem
cells served as positive controls. The fact that ^+5% of V,36+
cells were constantly found in the chimeras reconstituted with
I-E- cells may indicate that host-derived hemopoietic cells
persisting at low but variable amounts did not significantly
alter differentiation of Mls-la-specific T cells. V/38+ cells
were monitored as an internal positive control that revealed
efficient maturation of T cells in all the chimeras tested.
T Cells from Fully Allogeneic Chimeras Reconstituted with
I-E- (H-29) Bone Marrow Show In Vitro Reactivity to Host
Mb-la. We have previously demonstrated (14, 15) that fully
allogeneic B10.G (I-E - ) --> DBA/2 (I-E+) chimeras con-
Table 2.
￿
Clonal Deletion of V06+ Cells in Semiallogeneic Parent - F, Bone Marrow Chimeras Requires Donor I-E Expression
Donor
￿
Host
B10.D2
B10.D2
B10.S
B10.G
B10.D2
B10. G
DBA/2
(BALB.D2 x B10.S)Ft ￿1 .4
(BALB.D2 x BlO.G)F,
￿
1.7
(BALB.D2 x B10.S)Fl ￿4 .8
(BALB.D2 x B10.G)Fi ￿5 .6
(DBA/2 x B10.G)Ft
￿
0.6
(DBA/2 x B10.G)Fi
￿
5.3
(DBA/2 x B10.G)F,
￿
0.6
Mls-1' mice were irradiated with 950 rad and reconstituted with T cell-depleted bone marrow from the indicated strains. Analysis was performed
between 7 and 16 wk later. Means of three to four individual chimeras for V# expression are given as a proportion of the total CD4+ cells, respec-
tively. Chimerism was assessed by H-2 expression. SDs ranged between 0.2 and 4.7%.
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￿
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V06/CD4
tained 6.8% of V06+ T cells among their peripheral CD4+
lymphocytes. Surprisingly, in initial analyses of the functional
properties of chimeric T cells, we found strong host-specific
reactivity. After stimulation with host-type DBA/2 (Mls-
1') spleen cells, -30 U of IIr2/ml were produced (Table 3).
This response was specific for Mls-1' as shown by compar-
ison of BAL&D2-Mls' vs. congenic BALB/c (Mls-16) stimu-
latorcells. In contrast, lymphocytes from B10.D2 - DBA/2
chimeras containing very low levels of V06+ cells did not
produce significant amounts of ID2 when stimulated with
Mls-1' spleen cells. The control response after stimulation
with third-party allogeneic MHC antigens was comparable
for all cell populations. Thus, T cells from fully allogeneic
chimeras reconstituted with I-E- /H-2q bone marrow cells
exhibited reactivity to host Mls-1'.
Mls-1°-specfic Reactivity of Chimeric Lymphocytes In Vitro
Depends on the H-2 Haplotype ofthe Bone Marrow Donor. While
our studies were in progress, others published data from semi-
allogeneic parent - F1 chimeras using H-25 bone marrow
cells (16, 17). They demonstrated impaired clonal deletion
of V/66+ cells similar to our findings, but reported on func-
tional anergy ofMls-1'-specific T cells in their chimeras. Be-
cause this unresponsiveness of V#6+ cells was in contrast to
the Mls-1'-specific reactivity in our system, we analyzed
Mls-1a responsiveness of lymphocytes from parent -" F1
chimeras usingeither B10.S (H-2s) or B10.G (H-2q) donors.
As demonstrated above (Table 2), both chimeras made with
I-E- bone marrow cells, i.e., B10.S --" (BALB.D2-Mls' x
B10.S)Ft and B10.G --> (BALB.132-Mls' x B10.G)Fi
chimeras, revealed relatively high percentages of V06+ cells,
whereas in control chimeras reconstituted with B10.D2
(I-E+) bone marrow, most of the V06+ cells were deleted.
Fig. 1 demonstrates IIr2 responses to titrated stimulator
cells by chimeric lymphocytes, and their (3H]thymidine up-
take is shown in Table 4. In all cases, lymphocytes from
chimeras or control mice proliferated and secreted IIr2 after
stimulation with third-party allogeneic MHC antigens. How-
Percent lymph node cells expressing:
V/08/CD4 I-E H-213d H-2Dq
25 .9 33.6 ND ND
23.0 40.2 ND ND
20.5 2.1 ND ND
20.7 4.5 ND ND
18.3 36.3 97.3 1.9
13.2 2.4 1.8 99.6
17.9 ND 96.5 3.05 x 105 T cell-depleted stimulator spleen cells were incubated with 5 x 105 responder spleen cells from the chimeras or control mice indicated
in 96-well plates for48 h. Supernatants were assayedfor IL-2 content. Data are means ± SD of three to five individual mice andof triplicate cultures.
Percentages of expresison of V06 by responder lymphocytes have been published previously (15) .
ever, Mls-la-specific responses were variable. As expected, T
cells from chimeras reconstituted with MOM donor cells
(which clonally deleted V06+ cells) were not reactive to
Mls-1a stimulators Furthermore, lymphocytes from B10.S -->
STIMULATORS
Stimulators/well (x100.0001
Figure 1.
￿
Mls-1=-specific 11,2 production of lymphocytes from semial-
logeneic parent -+ F, bone marrow chimeras. Titrated T cell-depleted
stimulator spleen cells of the indicated genotype were incubated with
5 x 105responderlymphocyte from theindicatedchimeras (a-t1) or con-
trol mice (e ands in 96-well plates for 48 h. Supernatants were assayed
for 11,2 content.Data aremeansof triplicate cultures from twoindividual
mice.
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(BALB.D2-Mlsa x Bl0.S)Ft chimeras did not secrete IIr2
after stimulation with host-type MIS-la (BALB.D2-Mlsa x
B10.S)Ft spleen cells, suggesting anergy of the V06+ cells
found at levels of N5% in these animals. Interestingly, when
lymphocytes from the same chimeras were stimulated with
parental BALB.D2-Mlsa spleen cells, we detected weak pro-
liferation and ti7 U of IIT2/ml MLC supernatant. As ob-
served previously in fullyallogeneic chimeras (Table 3), B10.G
--> (BALB.D2-Mlsa x B10.G)Ft chimeras showed reactivity
to (BALB.D2-Mlsa x B10.G)Ft stimulators and were
strongly reactive to BALB.D2-Mlsa spleen cells. In summary,
T cell responsiveness to host Mls-la was absent in chimeras
reconstituted with MOM (I-E+) bone marrow, most prob-
ably due to clonal deletion of Mls-la-reactive cells. Further-
more, the Mls-la-specific response of chimeras reconstituted
with B10.S (I-E - ) bone marrow was very low against
BALB/D2-Mlsa stimulators, and no reactivity was found
after stimulation with host-type (BALB.D2-Mlsa x
B10.S)Ft stimulator cells. In contrast, lymphocytes derived
from chimeras reconstituted with B10.G (I-E-) bone
marrow cells were clearly reactive to Mls-la presented by pa-
rental or Fl stimulators.
MHC (I-E) Homozygous Mls-1° Stimulator Cells Induce
Stronger T Cell Responses than Heterozygous Stimulators. As
demonstrated in Fig. 1, the Mls-la-specific activation of chi-
meric T cells was clearly higher when parental stimulator
cells were used as compared with spleen cells derived from
Fl hybrid mice. We reasoned that this discrepancy may have
been due to a reduced MIS-la stimulatory capacity of F1 hy-
brid cells. To test this, the Mls-1'-reactive V06+ T cell hy-
brid RG17.16 was incubated with the various stimulator spleen
cells. As shown in Table 5, the response to homozygous
BALB.D2-Mlsa cells was significantly higher when com-
pared with heterozygous stimulators. In addition, we con-
firmed by flow cytometry that homozygous spleen cells ex-
pressed more I-E molecules than cells heterozygous at the
MHC locus. Therefore, it is suggested that the decreased
Mls-1' stimulatory capacity of spleen cells from Fl mice is
due to their lower I-E expression. Additional experiments
ruled out that heterozygosity at the Mls-1 locus by itselfwould
Table 3. SefMls-1°-specific IL-2 Production of Spleen Cells from Fully Allogeneic Chimeras
Responder spleen cells IL-2 produced after stimulation with spleen cells from :
Percent
Donor Host V06+/CD4+ BALB.D2 BALB/c DBA/2 B10.D2 B10.BR C57BL/6
U
B10.D2 DBA/2 0.4 <2 <2 <2 <2 22.1 -± 6.1 13.7 ± 3.2
B10.G y DBA/2 6.8 23 .6 ± 4.4 <2 29.9 ± 5.6 <2 28.9 ± 1.5 16.9 ± 3.7
MOM 9.3 31 .1 ± 4.5 <2 25.4 ± 3.6 <2 14.4 ± 5.0 14.4 ± 2.6
DBA/2 0.4 <2 2.8 <2 <2 29.2 ± 3.1 25.3 ± 2.6Table 4.
￿
SefA4h-1°-speck Proliferation of Lymphocytes from Semiallogeneic Parent -" F, Chimeras
5 x 105 irradiated (1,000 rad) T cell-depleted stimulator spleen cells were cultivated with 5 x 105 responder CD8- thymocytes or lymph node
cells from the chimeras or control mice indicated in 96-well plates and pulsed for the last 12 h of a 3-d incubation. The data (mean cpm x 10- 3
of three to four cultures after subtraction of background counts from cultures with responder cells alone) are from two chimeras of each group
measured in a representative experiment. Underlined values are significantly (p < 0.05; student's ttest) abovebackground levels. SDs ranged between
t3 and ±32% for thymocyte responders, and between ±4 and ±37% for responders from lymph nodes. IL-2 values measured in supernatants
of similar MLC are shown in Fig. 1.
Table 5.
￿
Mls-1° Stimulatory Capacity of Parental vs. F, Hybrid Spleen Cells of Different H-2 Haplotypes
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IL-2 produced by RG17.16 cells after
stimulation with titrated spleen cells
The Mls-11-reactive T cell hybrid RG17.16 (2 x 104 cells/well) was incubated with titrated T cell-depleted stimulator spleen cells in 96-well flat-
bottomed plates for48 h. Supernatants were assayed for IL-2 activity. Data aremean U IL-2/ml supernatant of triplicate cultures. Mean fluorescence
intensity of cells positively stained with mAb 14-4-4 specific for I-Edik is given from analyses of similar T cell-depleted spleen cells (from the mice
indicated), which were 91-95% I-E+ .
Donor
(H-2, Mls-1)
Responder lymphocytes
Host
(H-2, Mls-1) Tissue
[3H]Thymidine uptake after stimulation
with spleen cells from:
BALB.D2 BALB/c C57BL/6
B10.D2 -~ (BALB.D2 x B10.S)F, Thymus 0.1
cpm x 10 -3
<0.1 0.6
(d, b) (d/s, a/b) Thymus <0.1 <0.1 0.4
Lymph nodes <0.1 <0.1 6.6
Lymph nodes <0.1 <0.1 8.0
B10.D2 y (BALB.D2 x B10.G)F, Thymus <0.1 <0.1 _0.7
(d, b) (d/q, a/b) Thymus <0 .1 <0.1 _0 .3
Lymph nodes <0.1 <0.1 _9.3
Lymph nodes <0.1 <0.1 3.8
B10.S -~ (BALB.D2 x B10.S)F, Thymus _1.1 <0.1 _1.4
(s, b) (d/s, a/b) Thymus _1.0 <0.1 _0.9
Lymph nodes 3.8 <0.1 8.5
Lymph nodes 5.6 <0.1 7.6
B10.G -~ (BALB.D2 x B10.G)F, Thymus _4.4 <0.1 _0.7
(q, b) (d/q, a/b) Thymus _3.6 <0.1 _0.6
Lymph nodes 13 .1 <0.1 _6 .0
Lymph nodes 11 .7 <0.1 3.6
B10.D2 Thymus _5.9 <0.1 _0.3
(d, b) Lymph nodes 26 .3 <0.1 7.4
BALB .D2 Thymus <0.1 <0.1 3.5
(d, a) Lymph nodes <0.1 1.6 27.4
Stimulators from: 10, 5 x 10, 106
Mean fluorescence intensity
of I-E+ spleen cells
U
BALB.D2-Mls' 25 .0 57 75 133.2
(BALB.D2-Mls' x B10.S)F, 6.9 31 18 45.6
(BALB.D2-Mls' x B10.G)F, 6.2 31 35 62.8significantly reduce antigenicity of stimulator cells, because
spleen cells from (BALB.D2-Mlsa x BALB/c)Fi were simi-
larly Mls-12 stimulatory compared with BALB.D2-Mlsa cells
(data not shown).
Sf-Mls-1°-specfix In Vitro Proliferation of V06+ T Cells
afterAddition ofExogenous 11,2. We further investigated re-
sponsiveness of chimeric T cells by analyzing V06 expres-
sion in MLC after Mls-12 stimulation. Since functional
anergy in some systems appears to reflect defective 11,2 produc-
tion (30), we applied the following protocol. Responding
T cell blasts were isolated from 3-d MLC and re-incubated
in 11,2 containing medium for an additional 2 d. V06+/
CD4+ lymphocytes from chimeras that received B10.G bone
marrow expanded -10-fold when cocultured with BALB.D2-
Mlsa stimulator cells (Fig. 2). This increased proportion of
V06+/CD4+ cells was specific for Mls-1a. Lymphocytes
from chimeras reconstituted with B10.S stem cells showed
approximately fivefold expansion of the V06+/CD4+ subset
in response to Mls-1a. Control stimulation with spleen cells
from third-party C57BL/6 mice (H-2b) resulted in a pro-
liferative response in all cases, but no specific expansion of
V06+ T cells. In conclusion, these data indicate that "an-
ergic" V06+ cells from irradiated mice reconstituted with
B10.S bone marrow responded to strong Mls-1a stimulation
and addition of exogenous IL2.
RESPONDERS
relative cell number
￿
%V96/CD4 positive
recovered (x10.000) of cells recovered
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Figure 2.
￿
Mls-11-specific proliferation (left panel) and expansion of
Vfl6+/CD4+ cells (right panel) of lymphocytes from semiallogeneic
chimeras in the presence ofIIr2. Pooled lymph node and spleen cells from
two individual chimeras were stimulated with irradiated T cell-depleted
spleen cells. After 3 d, responding blasts were isolated and cultured for
an additional 48 h in l1r2. Recovered cells were counted (left panel) and
stained with V06-specific mAb. Data shown in the right panel are percent
V06+ cells normalized to total CD4+ cells. Measurement of
V06+/CD4+ were only done in cultures where numbers of viable cells
recovered allowed appropriate analyses. Numbers and proportions of
V136+/CD4+ cells in the starting population (before culture) are indi-
cated with black bars.
Tolerance to Mls-1a in Chimeras
Mls-1° Stimulatory Capacity ofChimeric Spleen Cells.
￿
The
finding that chimeras made with I-E - donor cells remained
healthy despite the presence of in vitro self-Mls-1'-reactive
T cells raised the question of reactivity of V06+ T cells in
vivo. Because B cells responsible for Mls-1a stimulation
(31-33) are very radiosensitive (34),we reasoned that the poten-
tially reactive T cells may not be activated in vivo because
the chimeras might lack Mls-1s stimulatory capacity, unless
they had been reconstituted with bone marrow cells expressing
both Mls-la and I-E determinants. To test this hypothesis,
the Mls-1a reactive V06+ T cell hybrid RG17.16 was in-
cubated with stimulator spleen cells from the various chimeras
(Table 6). IL2 secretion was observed when stimulator cells
originated from DBA/2 (I-E+, Mls-1a) mice or chimeras
reconstituted with DBA/2 bone marrow. In contrast, chi-
meric spleen cells from Mls-1' hosts reconstituted with bone
marrow from B10.G or B10.S (both I-E - and Mls-1b), or
B10.D2 (I-E+, Mls-1b) donors were not stimulatory. Thus,
no Mls-1a stimulatory capacity was found in spleens of
chimeras containing V06+ T cells that had escaped clonal
deletion.
Discussion
The data presented herein confirm and extend recent studies
(14-18) indicating that clonal deletion of self-reactive TCR
Vii domains in irradiation bone marrow chimeras requires
expression of I-E by donor-derived bone marrow cells. Thus,
Va6+ (Mls-la-specific) cells derived from H-2q or H-2S (I-
E- ) bone marrow were not efficiently deleted in irradiated
H-2dxq or H-2ds hosts of Mls-1a genotype. This contrasts
with H-2a (I-E+) bone marrow chimeras that effectively
deleted V)36+ cells in both Fl recipients. Similarly, Rams-
dell et al. (16) and Roberts et al. (17) have recently shown
that H-25 (I-E -) bone marrow is not effective in inducing
deletion of V06+ or V017a+ cells in irradiated I-E+
recipients expressing the appropriate self-antigen (Mls-1a or
I-E plus an unknown ligand for Va17a) . Collectively, these
studies are compatible with the notion that in these systems
clonal deletion is the result of contact between TCR on de-
veloping immature lymphocytes and self-antigens presented
by I-E+ hemopoietic cells (such as B cells, dendritic cells,
or macrophages). In this model, radioresistant (presumably
epithelial) cells in the thymus apparently do not contribute
significantly to the deletion process.
Clonal anergy has been proposed to maintain tolerance to
self-antigens in cases when clonal deletion does not (or cannot)
occur (21-25); e.g., anergy of V06+ cells to Mls-12 has re-
cently been demonstrated in several different experimental
systems (16, 17, 19, 20). Using irradiation bone marrow
chimeras, both Ramsdell et al. (16) and Roberts et al. (17)
have shown that V06+ T cells in P -> Fl chimeras derived
from H-2s (I-E - ) donors are selectively unresponsive to
Mls-1a in vitro. The present study largely confirms these
findings (in s -> d x s chimeras), although a weak response
of chimeric T cells could be observed when Mls-1a was pre-
sented on MHC homozygous (d x d) stimulator cells. In
striking contrast, V06+ T cells in congenic chimeras ofTable 6.
￿
Mb-14 Stimulatory Capacity of Chimeric Spleen Cells
The Mls-1--reactive T cell hybrid RG17.16 (2 x 1!04) was incubated for 48 h with stimulator spleen cells from the chimeras or control mice as
indicated. Supernatants were assayed for IL-2 activity. Data are means of triplicate cultures from two individual mice.
H-2q donor bone marrow type (q --> d x q) responded
strongly to host Mls-11 antigens in vitro, as assessed by
proliferation and IIr2 production. The pattern of responsive-
ness of these chimeric T cells to a panel of stimulator cells
indicated further that they were tolerant to host MHC
(H-2d) but reacted to third-party allogeneic MHC. Failure
of tolerance induction to host Mls-1' therefore markedly
contrasts with successful tolerance induction to host MHC
products. This dichotomy of reactivity to Mls-1' vs. toler-
ance to MHC, first demonstrated by Morrissey et al. (35),
is difficult to interpret without knowledge of the molecular
structure of Mls-1' gene products. One possible explanation
might be that MHC products presented by radioresistant (ep-
ithelial) thymic cells may preferentially induce clonal dele-
tion (or functional anergy) because of their high level of ex-
pression, or because of some intrinsic property of the MHC
molecules themselves. The ability of thymic epithelium to
tolerize across MHC barriers is consistent with a number
of tissue-grafting studies (36-38). However, other studies on
tolerance to MHC products expressed by the radioresistant
component ofthe thymus have revealed tolerance in vivo but
some reactivity in vitro (see references 39-48 and 49 for
review).
Induction of anergy of V06+ T cells to self Mls-1' in
s --> d x s but not q --> d x q chimeras is surprising. In
terms of I-E expression and ability to present Mls-1' to the
Mls-1'-specific hybrid RG17.16, no quantitative differences
could be found between spleen cells from the H-2 congenic
d x s and d x q F, hybrid hosts utilized. Assuming these
properties applyalso to cells in the thymus, it seems unlikely
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that the differential induction of clonal anergy to Mls-11 in
these chimeras can be explained by interaction ofdeveloping
T cellswith host components. We therefore favor the notion
that donor-derived hemopoietic cells are involved in the clonal
anergy phenomenon. Itis noteworthy that several studies (50),
including our own (29), have recently revealed that there is
a hierarchy of I-A alleles with respect to their capacity to
clonally delete V)36+ cells in MHC congenic, recombinant
inbred, and transgenic mouse strains of Mls-11 genotype that
lack I-E expression. Thus, I-AS gene products can support
a significant (although limited) deletion of V#6+ cells,
whereas I-A9 gene products seem to be ineffective. Given
these results, it is possible that Mls-1' is differentially
"presented" on radiosensitive (hemopoietic) thymic APC ex-
pressing I-AS or I-Aq. Potential differences in the affinity of
V06+ TCR for Mls-11 in association with I-AS and I-A9 may
lead to anergy in one case (I-As) but not in the other (I-A9).
Accordingly, the fate ofdevelopingimmature thymocytes ex-
pressing potentially autoreactive TCR (at leastfor certain an-
tigens such as Mls-1') would be largely (if not exclusively)
determined by the relative affinity of the TCR interaction
with self-antigen presented on MHC class II-positive
hemopoietic-derived cells. Thus, deletion, anergy, or no de-
tectable effect would result from high, intermediate, or low
affinity interactions (corresponding to H-2d, H-2°, or H-29
presenting cells, respectively, in the case of self-Mls-1'). In
contrast to similar studies (16, 17), the results summarized
here suggest that interactions of TCR on immature thymo-
cytes with radioresistant (presumably epithelial) cells would
not be relevant for negative selection (manifested either as
Donor
Stimulators from:
Host 106
IL-2 produced by RG17.16 cells
stimulation with titrated spleen
5 x 105
after
cells
10,
U
B10.D2 DBA/2 <2 <2 ND
B10.G DBA/2 <2 <2 ND
B10.D2 (DBA/2 x B10.G)F, <2 <2 <2
B10.G (DBA/2 x B10.G)F, <2 <2 <2
DBA/2 (DBA/2 x B10.G)F, 51.3 48.2 13.7
B10.D2 (BALB.D2 x B10.S)F, <2 <2 ND
B1002 (BALB .D2 x B10.G)F, <2 <2 ND
B10.S y (BALB.D2 x B10.S)F, <2 <2 ND
B10.G (BALB.D2 x B10.G)F, <2 <2 ND
B10.D2 <2 <2 <2
DBA/2 48.4 45.3 14.1deletion or anergy) in the Mls-1' system. It should be em-
phasized, however, that thymic epithelial cells play a role in
negative selection in other antigenic systems, as suggested
convincingly by several reports (39-49, 51).
Despite the potential for in vitro reactivity to Mls-la,
Mls-1a recipients reconstituted with H-29 bone marrow cells
survived >1 yr without clinical symptoms of disease. Also,
the chimeric spleen cells when adoptively transferred to ir-
radiated Ml-1a recipients failed to provoke obvious graft-vs.-
host disease (not shown). This parallels results from similar
chimeras reported by Ramsdell et al. (16). The lack of reac-
tivity may be interpreted as a form of "anergy" of chimeric
V06+ cells in vivo. However, this may not necessarily be so,
since Korngold and Sprent (52) have shown that adoptive
transfer of Mls-1b spleen cells into irradiated Mls-1a recipients
does not always cause lethal graft-vs.-host disease. An alter-
native mechanism to explain lack of pathogenic activity of
Mls-1a-specific T cells in vivo may simply be the absence of
appropriately presented Mls-la in these chimeras. This is sug-
gested by the inability of chimeric spleen cells to stimulate
Ilr2 production by the Mls-1a-specific T cell hybrid RG17.16
shown in Table 6. Possibly, Va6+ cells may not be harmful
in the chimeras because of inadequate Mls-1° presentation
in vivo.
It is noteworthy that spleen cells from d - d x q and
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